Skip to content

Jabre Capital Partners S.A. 13F Holdings · last filed Q4 2018

Jabre Capital Partners S.A. reported 15 securities worth $87.82M in its SEC 13F filing for Q4 2018 (period ended 2018-12-31). Top holdings: VWO (19.22%), XLF (12.75%), CLVS (9.18%). Among its top 25 positions this quarter: 9 new, 3 added, 7 trimmed, 3 exited.

RankTickerCompanyValue% PortfolioSharesAction
1VWOVANGUARD INTL EQUITY INDEX F$16.9M19.22%443,082New
2XLFSELECT SECTOR SPDR TR$11.2M12.75%470,000Trimmed
3CLVSCLOVIS ONCOLOGY INC$8.1M9.18%0Added
4GEGENERAL ELECTRIC CO$7.6M8.62%1.0MNew
5EEMISHARES TR$7.4M8.43%189,460Trimmed
6QQQINVESCO QQQ TR$6.9M7.90%45,000New
7SPWRQSUNPOWER CORP$5.6M6.34%0Added
8EWZISHARES INC$5.5M6.31%145,166New
9PGENINTREXON CORP$3.1M3.49%0Hold
10INSMINSMED INC$3.1M3.48%0Added
11NXHOVERSTOCK COM INC DEL$1.8M2.09%135,000Trimmed
12ONON SEMICONDUCTOR CORP$1.6M1.83%0Trimmed
13ACORQACORDA THERAPEUTICS INC$1.5M1.68%0New
14SYNASYNAPTICS INC$1.3M1.49%0New
15VACMARRIOTT VACATIONS WRLDWDE C$1.3M1.48%0New
16DHID R HORTON INC$1.2M1.42%36,000Hold
17MKSIMKS INSTRUMENT INC$1.0M1.18%16,000Hold
18ATSGAIR TRANSPORT SERVICES GRP I$958,0001.09%0New
19EXEELCHESAPEAKE ENERGY CORP$798,0000.91%0New
20CENXCENTURY ALUM CO$429,0000.49%58,742Trimmed
21MUMICRON TECHNOLOGY INC$349,0000.40%11,000Trimmed
22PCRXPACIRA PHARMACEUTICALS INC$201,0000.23%0Trimmed
23NXP SEMICONDUCTORS N V$00.00%0Exited
24ADSKAUTODESK INC$00.00%0Exited
25ALDRALDER BIOPHARMACEUTICALS INC$00.00%0Exited

Source: SEC Form 13F filings · as of 2018-12-31

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR